Skip to main content
Top
Published in: Abdominal Radiology 7/2017

01-07-2017 | JSAR Submission

Imaging features of papillary renal cell carcinoma with cystic change-dominant appearance in the era of the 2016 WHO classification

Authors: Yukiko Honda, Keisuke Goto, Yuko Nakamura, Hiroaki Terada, Kazuhiro Sentani, Wataru Yasui, Yohei Sekino, Tetsutaro Hayashi, Jun Teishima, Akio Matsubara, Tomoyo Fuji, Yoko Kaichi, Toru Higaki, Yasutaka Baba, Makoto Iida, Kazuo Awai

Published in: Abdominal Radiology | Issue 7/2017

Login to get access

Abstract

Purpose

Papillary renal cell carcinoma (P-RCC) typically exhibits a homogeneous, solid hypovascular mass; P-RCC with a cystic appearance is atypical. Tubulocystic RCC (TC-RCC), a newly proposed entity for renal tumors in the 2016 WHO classification, and cystic papillary RCC, may yield similar imaging findings. Therefore, we investigated the incidence of papillary RCC with cystic changes and compared its CT and pathologic features to differentiate between two entities.

Methods

We retrospectively evaluated 26 consecutive patients diagnosed with P-RCC. Two radiologists consensually identified dominant masses indicative of cystic changes on CT scans and recorded their Bosniak classification. In addition, two pathologists inspected the whole area of tumors macroscopically, labeled them as solid- or cystic change-dominant tumors, determined the pathogenesis of the cystic components (necrosis or hemorrhage), and recorded their inherent cystic characteristics (with/without TC-RCC components). We defined masses with cystic changes involving more than 50% of the entire tumor as cystic change-dominant tumors.

Results

Of the 26 tumors, 7 (27%) were diagnosed cystic change-dominant based on imaging and pathologic findings, of these, 2 were classified as Bosniak type III and 5 as Bosniak type IV. The pathologists confirmed that two type IV tumors demonstrated extensive necrosis and one type IV tumor revealed extensive hemorrhage. Four P-RCCs (type III and IV, 2 each) were of a mixed type harboring both solid and cystic components. Only one tumor exhibited a multilocular cystic appearance. All 7 cystic change-dominant P-RCCs were pathologically diagnosed as a pure P-RCC without TC-RCC components.

Conclusion

While P-RCCs may contain cystic features, the multilocular type of cystic P-RCC is rare.
Literature
1.
3.
go back to reference Brinker DA, Amin MB, de Peralta-Venturina M, et al. (2000) Extensively necrotic cystic renal cell carcinoma: a clinicopathologic study with comparison to other cystic and necrotic renal cancers. Am J Surg Pathol 24(7):988–995CrossRefPubMed Brinker DA, Amin MB, de Peralta-Venturina M, et al. (2000) Extensively necrotic cystic renal cell carcinoma: a clinicopathologic study with comparison to other cystic and necrotic renal cancers. Am J Surg Pathol 24(7):988–995CrossRefPubMed
7.
go back to reference Kuroda N, Matsumoto H, Ohe C, et al. (2013) Review of tubulocystic carcinoma of the kidney with focus on clinical and pathobiological aspects. Pol J Pathol 64(4):233–237CrossRefPubMed Kuroda N, Matsumoto H, Ohe C, et al. (2013) Review of tubulocystic carcinoma of the kidney with focus on clinical and pathobiological aspects. Pol J Pathol 64(4):233–237CrossRefPubMed
14.
16.
go back to reference Chen Y, Wu N, Xue T, Hao Y, Dai J (2014) Comparison of contrast-enhanced sonography with MRI in the diagnosis of complex cystic renal masses. J Clin Ultrasound . doi:10.1002/jcu.22232 Chen Y, Wu N, Xue T, Hao Y, Dai J (2014) Comparison of contrast-enhanced sonography with MRI in the diagnosis of complex cystic renal masses. J Clin Ultrasound . doi:10.​1002/​jcu.​22232
18.
go back to reference Akita H, Jinzaki M, Akita A, et al. (2014) Renal cell carcinoma in patients with acquired cystic disease of the kidney: assessment using a combination of T2-weighted, diffusion-weighted, and chemical-shift MRI without the use of contrast material. J Magn Reson Imaging 39(4):924–930. doi:10.1002/jmri.24226 CrossRefPubMed Akita H, Jinzaki M, Akita A, et al. (2014) Renal cell carcinoma in patients with acquired cystic disease of the kidney: assessment using a combination of T2-weighted, diffusion-weighted, and chemical-shift MRI without the use of contrast material. J Magn Reson Imaging 39(4):924–930. doi:10.​1002/​jmri.​24226 CrossRefPubMed
21.
go back to reference Tran T, Jones CL, Williamson SR, et al. (2016) Tubulocystic renal cell carcinoma is an entity that is immunohistochemically and genetically distinct from papillary renal cell carcinoma. Histopathology 68(6):850–857. doi:10.1111/his.12840 CrossRefPubMed Tran T, Jones CL, Williamson SR, et al. (2016) Tubulocystic renal cell carcinoma is an entity that is immunohistochemically and genetically distinct from papillary renal cell carcinoma. Histopathology 68(6):850–857. doi:10.​1111/​his.​12840 CrossRefPubMed
Metadata
Title
Imaging features of papillary renal cell carcinoma with cystic change-dominant appearance in the era of the 2016 WHO classification
Authors
Yukiko Honda
Keisuke Goto
Yuko Nakamura
Hiroaki Terada
Kazuhiro Sentani
Wataru Yasui
Yohei Sekino
Tetsutaro Hayashi
Jun Teishima
Akio Matsubara
Tomoyo Fuji
Yoko Kaichi
Toru Higaki
Yasutaka Baba
Makoto Iida
Kazuo Awai
Publication date
01-07-2017
Publisher
Springer US
Published in
Abdominal Radiology / Issue 7/2017
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1189-1

Other articles of this Issue 7/2017

Abdominal Radiology 7/2017 Go to the issue

Classics in Abdominal Imaging

Apple core sign in colorectal cancer

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.